GRI Bio, Inc.
GRI
$1.60
$0.04412.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.55M | 4.92M | 4.47M | 4.32M | 4.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 0.00 | -250.00K |
| Total Operating Expenses | 10.03M | 9.39M | 8.24M | 8.31M | 8.37M |
| Operating Income | -10.03M | -9.39M | -8.24M | -8.31M | -8.37M |
| Income Before Tax | -13.87M | -13.23M | -12.07M | -8.26M | -8.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.87 | -13.23 | -12.07 | -8.26 | -8.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.87M | -13.23M | -12.07M | -8.26M | -8.28M |
| EBIT | -10.03M | -9.39M | -8.24M | -8.31M | -8.37M |
| EBITDA | -10.03M | -9.39M | -8.23M | -8.30M | -8.36M |
| EPS Basic | -26.39 | -86.92 | -182.23 | -293.45 | -401.11 |
| Normalized Basic EPS | -14.06 | -51.89 | -111.46 | -108.98 | -101.84 |
| EPS Diluted | -34.25 | -94.79 | -190.09 | -293.45 | -401.11 |
| Normalized Diluted EPS | -14.06 | -51.89 | -111.46 | -108.98 | -101.84 |
| Average Basic Shares Outstanding | 3.41M | 1.24M | 732.00K | 241.00K | 55.10K |
| Average Diluted Shares Outstanding | 3.41M | 1.24M | 732.00K | 259.10K | 91.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |